These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27166271)

  • 41. Predictive importance of galectin-3 for recurrence of non-small cell lung cancer.
    Kataoka Y; Igarashi T; Ohshio Y; Fujita T; Hanaoka J
    Gen Thorac Cardiovasc Surg; 2019 Aug; 67(8):704-711. PubMed ID: 30903521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reactive oxygen species modulator 1 (Romo1) overexpression is an independent predictor of poor survival in NSCLC patients who undergo surgical resection.
    Lee SH; Min JW; Lee JS; Kim CH; Yoo YD; Lee EJ; Min KH; Hur GY; Lee SH; Lee SY; Kim JH; Lee SY; Shin C; Shim JJ; Kang KH; In KH
    Lung Cancer; 2015 Jan; 87(1):45-52. PubMed ID: 25468147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The high-temperature requirement factor A3 (HtrA3) is associated with acquisition of the invasive phenotype in oral squamous cell carcinoma cells.
    Moriya Y; Uzawa N; Morita T; Mogushi K; Miyaguchi K; Takahashi K; Michikawa C; Sumino J; Tanaka H; Harada K
    Oral Oncol; 2015 Jan; 51(1):84-9. PubMed ID: 25456008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
    Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
    Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer.
    Shargall Y; de Perrot M; Keshavjee S; Darling G; Ginsberg R; Johnston M; Pierre A; Waddell TK
    Lung Cancer; 2004 Sep; 45(3):357-63. PubMed ID: 15301876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer.
    Herpel E; Jensen K; Muley T; Warth A; Schnabel PA; Meister M; Herth FJ; Dienemann H; Thomas M; Gottschling S
    Anticancer Res; 2011 Dec; 31(12):4491-500. PubMed ID: 22199321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HTRA3 is reduced in ovarian cancers regardless of stage.
    Zhao M; Ding JX; Nie GY; Wei J; Li Y; Yin XY; Chen Q
    Cancer Invest; 2014 Nov; 32(9):464-9. PubMed ID: 25274382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
    Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M
    Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer.
    Hamaji M; Allen MS; Cassivi SD; Deschamps C; Nichols FC; Wigle DA; Shen KR
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):683-90; discussion 690-1. PubMed ID: 23414986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.
    Cao X; Tang Z; Huang F; Jin Q; Zhou X; Shi J
    Oncotarget; 2017 Feb; 8(8):12812-12819. PubMed ID: 28086212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The expression of astrocyte elevated gene-1 in human non-small-cell lung cancer and its relationship with postoperative chemotherapy and radiotherapy.
    Lu S; Xu J; Xu X; Hu S; Li B; Li W
    Histopathology; 2015 Dec; 67(6):817-26. PubMed ID: 25913216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteopontin combined with CD44v6, a novel prognostic biomarker in non-small cell lung cancer undergoing curative resection.
    Sun BS; Li Y; Zhang ZF; You J; Wang CL
    Ann Thorac Surg; 2013 Dec; 96(6):1943-51. PubMed ID: 24094519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
    Cho HJ; Kim HR; Park YS; Kim YH; Kim DK; Park SI
    Surg Oncol; 2015 Dec; 24(4):329-34. PubMed ID: 26690822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
    Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
    Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
    Shoji F; Haratake N; Akamine T; Takamori S; Katsura M; Takada K; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Feb; 37(2):741-747. PubMed ID: 28179325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methylation induced gene silencing of HtrA3 in smoking-related lung cancer.
    Beleford D; Liu Z; Rattan R; Quagliuolo L; Boccellino M; Baldi A; Maguire J; Staub J; Molina J; Shridhar V
    Clin Cancer Res; 2010 Jan; 16(2):398-409. PubMed ID: 20068077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.